In NPH patients, β-Amyloid peptides 42 and 40 measured in CSF are significantly reduced compared to the healthy population but are not dissimilar to those in AD patients; however, total Tau and p-tau are significantly lower compared to AD patients [41, 42]. This evidence concerns the gene MAPT and Alzheimer disease.